Press release
Cunesoft GmbH and Jordan’s Drugstore Owners Association (DOA) Announce Strategic Partnership
Munich, Germany and Amman, Jordan — August 21, 2019 — Today, Cunesoft GmbH and DOA have announced their strategic partnership that will make eCTD submission software available to the members of DOA.“We are very excited to be able to work with DOA and bring Cunesoft’s cune-eCTD solution to DOA’s 19 corporate members,” said Rainer Schwarz, CEO at Cunesoft.
DOA’s members will now be able to easily license cune-eCTD in order to comply with Jordan’s eCTD submission requirement. “It was very important to us at DOA to partner with a leading provider of eCTD software that will be easy to use for our members,” said Thamer Obeidat, Secretary General of DOA. “Cunesoft’s software along with their positive industry reputation were key in developing this strategic partnership.”
Cunesoft’s cune-eCTD offers compliance with Jordan’s requirement for eCTD submissions while also including a seamlessly integrated document management capability.
About DOA:
The Drugstore Owners Association (DOA) was established in 1972 as a non-profit NGO to manage the relationship among the major pharmaceutical importers and distributors in Jordan as well as represent their professional and commercial interests with the public and private sector entities in the health care field.
DOA boasts the membership of 19 members whose operations account for a significant share of Jordan’s innovative pharmaceutical imports and who represent all the multinational R&D pharmaceutical manufacturers. For more information, visit www.doajo.net.
About Cunesoft:
Cunesoft GmbH is a provider of intelligent regulatory software and services for all segments within the life sciences industry. Solutions include management of eCTD, xEVMPD, IDMP data and document management as well as regulatory information management (RIM). Automated data mining based on NLP and Deep Learning algorithms complement the product portfolio. Software provisioning is provided as Private Software as a Service (SaaS). The company is headquartered in Munich (Germany) with international offices in the UK, US and India.
For more information, visit https://cunesoft.com/ .
Cunesoft GmbH
Luise-Ullrich-Strasse 20
80636 Munich, Germany
Neringa Antanaityte
About Cunesoft:
Cunesoft GmbH is a provider of intelligent regulatory software and services for all segments within the life sciences industry. Solutions include management of eCTD, xEVMPD, IDMP data and document management as well as regulatory information management (RIM). Automated data mining based on NLP and Deep Learning algorithms complement the product portfolio. Software provisioning is provided as Private Software as a Service (SaaS). The company is headquartered in Munich (Germany) with international offices in the UK, US and India.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cunesoft GmbH and Jordan’s Drugstore Owners Association (DOA) Announce Strategic Partnership here
News-ID: 1824828 • Views: …
More Releases for DOA
Key Influencer in the Drugs of Abuse (DOA) Testing Market 2025: Rising Demand Fo …
What combination of drivers is leading to accelerated growth in the drugs of abuse (doa) testing market?
The expected rise in demand for treatment of drug abuse is predicted to spur the growth of the drugs of abuse (DOA) testing market. The term drug or substance abuse pertains to the injurious use of substances in quantities harmful to the user and others. Drug testing is a means to detect unnatural compounds…
Global At-Home Drug of Abuse (DOA) Testing Market Imapct of AI and Automation
At-Home Drug of Abuse (DOA) Testing Market Impact of AI and Automation
In 2022, the At-Home Drug of Abuse (DOA) Testing market was valued at approximately USD 1.2 billion, with an anticipated compound annual growth rate (CAGR) of 7.5% projected through 2027. This growth reflects increasing consumer demand for privacy and convenience in drug testing solutions, driven by rising awareness of substance abuse and stringent regulations. The market's expansion is supported…
Dioctyl Adipate (DOA) Market Analysis and Future Prospects for 2030
The world of the dioctyl adipate (doa) market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a rapidly changing…
Drugs of Abuse (DOA) Testing Market is Growing at CAGR of 10.25% by 2030
A worldwide Drugs of Abuse (DOA) Testing market report is the best to know the trends and opportunities in Healthcare industry. The forecast, analysis, evaluations and estimations carried out in this business report are all based upon the well established tools and techniques such as SWOT analysis and Porter's Five Forces analysis. These are the authentic tools used in market analysis on which businesses can trust confidently. The credible Drugs…
At-Home DOA Testing Market : Business Overview and Global Development Trends
Global At-Home DOA Testing Market: Overview
Developing unlawful medications use among young people, rising number of initiatives by the administration organizations to lessen the medication misuse levels, and expanded creation of engineered cannabinoids, bath salts, and other rising medications are boosting the interest for at-home DOA testing items in the market.
A report by Transparency Market Research (TMR) on the global at-home DOA testing market market is an adroit explanation…
DOA Testing Market Size, Leaders, Segment Analysis and Forecast Report 2023
The increasing adoption of drug of abuse (DOA) testing at the organizational level, growing number of road accidents and deaths, and rising consumption of illicit drugs are some of the reasons behind the growth of the DOA testing market. In 2016, the market generated a revenue of $4.8 billion, and it is predicted to advance at a CAGR of 9.6% during the forecast period (2017–2023). Drug testing refers to the…
